| P2093 | author name string | Tomoki Nakashima | |
| | Fumiyuki Sasaki | |
| | Mikihito Hayashi | |
| | Takehito Ono | |
| P2860 | cites work | CCR6 identifies lymphoid tissue inducer cells within cryptopatches | Q82866177 |
| | The Tumor Necrosis Factor Superfamily Member RANKL Suppresses Effector Cytokine Production in Group 3 Innate Lymphoid Cells | Q88954027 |
| | Metastatic niche functions and therapeutic opportunities | Q90526088 |
| | Role of the RANK/RANKL Pathway in Multiple Myeloma | Q90858649 |
| | The RANK-RANKL axis: an opportunity for drug repurposing in cancer? | Q91104635 |
| | Antigen presentation and adaptive immune responses in skin | Q91160420 |
| | Osteoporosis | Q91271255 |
| | Effects of the anti-RANKL antibody denosumab on joint structural damage in patients with rheumatoid arthritis treated with conventional synthetic disease-modifying antirheumatic drugs (DESIRABLE study): a randomised, double-blind, placebo-controlled | Q91622660 |
| | Rethinking Thymic Tolerance: Lessons from Mice | Q91900695 |
| | RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass | Q92237916 |
| | FDA approves first-in-class osteoporosis drug | Q92503196 |
| | Osteoimmunology: evolving concepts in bone-immune interactions in health and disease | Q92668034 |
| | Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche | Q92759524 |
| | Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer | Q93051641 |
| | Emerging Functions of RANKL in Lymphoid Tissues | Q21131222 |
| | Human osteoclast-poor osteopetrosis with hypogammaglobulinemia due to TNFRSF11A (RANK) mutations | Q24310432 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells | Q24315251 |
| | Central control of fever and female body temperature by RANKL/RANK | Q24321735 |
| | Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis | Q24324701 |
| | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer | Q24605866 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | RANK-RANKL signalling in cancer | Q26747442 |
| | Immune regulation of bone metastasis | Q27005871 |
| | Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche. | Q27316833 |
| | RANKL Employs Distinct Binding Modes to Engage RANK and the Osteoprotegerin Decoy Receptor | Q27674275 |
| | Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke | Q28078744 |
| | Osteopetrosis and its relevance for the discovery of new functions associated with the skeleton | Q28085259 |
| | Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis | Q28141482 |
| | The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development | Q28142247 |
| | Matrix-embedded cells control osteoclast formation | Q28247746 |
| | Evidence for osteocyte regulation of bone homeostasis through RANKL expression | Q28247757 |
| | Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone | Q28267634 |
| | RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 |
| | Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems | Q28294477 |
| | RANK ligand mediates progestin-induced mammary epithelial proliferation and carcinogenesis | Q28294501 |
| | IKKalpha provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development | Q28508430 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype | Q28609693 |
| | RANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal Epithelium | Q29397534 |
| | Innate lymphoid cells--a proposal for uniform nomenclature | Q29617431 |
| | Osteocytes mediate the anabolic actions of canonical Wnt/β-catenin signaling in bone | Q30619950 |
| | Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway | Q31032805 |
| | Recent advances in the management of osteoporosis | Q33672136 |
| | OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice | Q33730470 |
| | Emerging therapeutic opportunities for skeletal restoration | Q34161867 |
| | Juvenile Paget's disease with heterozygous duplication within TNFRSF11A encoding RANK | Q34307564 |
| | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit | Q34750367 |
| | Prostaglandin E2-prostaglandin E receptor subtype 4 (EP4) signaling mediates UV irradiation-induced systemic immunosuppression | Q34835869 |
| | Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene | Q35438270 |
| | Panostotic expansile bone disease with massive jaw tumor formation and a novel mutation in the signal peptide of RANK. | Q35568480 |
| | Rank signaling links the development of invariant γδ T cell progenitors and Aire(+) medullary epithelium | Q36011240 |
| | Receptor activator of nuclear factor κB ligand (RANKL) protein expression by B lymphocytes contributes to ovariectomy-induced bone loss | Q36216058 |
| | RANKL-RANK interaction in immune regulatory systems | Q36412789 |
| | Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles | Q36810697 |
| | RANKL/RANK control Brca1 mutation-driven mammary tumors | Q37457304 |
| | An essential role for medullary thymic epithelial cells during the intrathymic development of invariant NKT cells | Q37627734 |
| | New insights into osteoclastogenic signaling mechanisms | Q38019255 |
| | Stromal infrastructure of the lymph node and coordination of immunity | Q38286890 |
| | Idiopathic hyperphosphatasia and TNFRSF11B mutations: relationships between phenotype and genotype. | Q38346910 |
| | Intestinal M cells | Q38658382 |
| | AIRE expands: new roles in immune tolerance and beyond. | Q38773105 |
| | Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus | Q39197051 |
| | RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers. | Q39670403 |
| | LTbetaR signaling induces cytokine expression and up-regulates lymphangiogenic factors in lymph node anlagen | Q39986041 |
| | Identification of subepithelial mesenchymal cells that induce IgA and diversify gut microbiota. | Q40230484 |
| | Regulation of cancer cell migration and bone metastasis by RANKL. | Q40298349 |
| | Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression. | Q41459925 |
| | RANK signals from CD4(+)3(-) inducer cells regulate development of Aire-expressing epithelial cells in the thymic medulla | Q41868543 |
| | Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction | Q41927546 |
| | Juvenile Paget's disease: the second reported, oldest patient is homozygous for the TNFRSF11B "Balkan" mutation (966_969delTGACinsCTT), which elevates circulating immunoreactive osteoprotegerin levels | Q42163993 |
| | Marginal reticular cells: a stromal subset directly descended from the lymphoid tissue organizer. | Q42234109 |
| | Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification | Q42994159 |
| | Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury | Q44579479 |
| | Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis | Q44688981 |
| | RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway | Q46072800 |
| | RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota | Q46167903 |
| | Langerhans Cells-Programmed by the Epidermis. | Q47109271 |
| | RANK rewires energy homeostasis in lung cancer cells and drives primary lung cancer. | Q47140509 |
| | The anti-tumor effect of RANKL inhibition in malignant solid tumors - A systematic review. | Q47386961 |
| | Ultraviolet radiation-induced immunosuppression and its relevance for skin carcinogenesis | Q47840579 |
| | Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems. | Q47944184 |
| | RANKL (Receptor Activator of NFκB Ligand) Produced by Osteocytes Is Required for the Increase in B Cells and Bone Loss Caused by Estrogen Deficiency in Mice | Q48039377 |
| | Osteoprotegerin deficiency and juvenile Paget's disease | Q48292818 |
| | Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain | Q48502190 |
| | RANKL and RANK: From Mammalian Physiology to Cancer Treatment. | Q48568949 |
| | Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System | Q49133217 |
| | Host defense against oral microbiota by bone-damaging T cells. | Q49912580 |
| | Recent advances in osteoclast biology. | Q50215136 |
| | Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL. | Q50335960 |
| | Intragenic SNP haplotypes associated with 84dup18 mutation in TNFRSF11A in four FEO pedigrees suggest three independent origins for this mutation. | Q50457960 |
| | Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. | Q50482693 |
| | Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. | Q50484870 |
| | Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification. | Q50492455 |
| | The cytokine RANKL produced by positively selected thymocytes fosters medullary thymic epithelial cells that express autoimmune regulator. | Q53453365 |
| | RANKL expressed on synovial fibroblasts is primarily responsible for bone erosions during joint inflammation. | Q53487298 |
| | Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells | Q57184743 |
| | CNS infection and immune privilege | Q57476572 |
| | Lineage Relationship Analysis of RORγt+Innate Lymphoid Cells | Q57520258 |
| | Coupling of bone resorption and formation by RANKL reverse signalling | Q59051790 |
| | Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis | Q60921418 |
| | Soluble RANKL contributes to osteoclast formation in adult mice but not ovariectomy-induced bone loss | Q61135621 |
| | Novel homozygous mutations in the osteoprotegerin gene TNFRSF11B in two unrelated patients with juvenile Paget's disease | Q62129297 |
| | RANKL is a therapeutic target of bone destruction in rheumatoid arthritis | Q64096832 |
| | One Disease, Many Genes: Implications for the Treatment of Osteopetroses | Q64228409 |
| | Innate Lymphoid Cells in Mucosal Immunity | Q64255314 |
| | Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines | Q74269794 |
| | Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis | Q77435071 |
| P304 | page(s) | 2 | |
| P577 | publication date | 2020-02-07 | |
| P1433 | published in | Inflammation and Regeneration | Q27723951 |
| P1476 | title | RANKL biology: bone metabolism, the immune system, and beyond | |
| P478 | volume | 40 | |